Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by jimsenioron Nov 19, 2022 2:57pm
231 Views
Post# 35112851

RE:"Griproom" article - 10 signs your company is to be acquired

RE:"Griproom" article - 10 signs your company is to be acquiredI have been looking for such advice, and have bookmarked this.

Just finished a book  - The Tao of Charlie Munger - A Compilation of Quotes.

#13 When To Bet Heavily

You should remember that good ideas are rare - when the odds are greatly in your favor, bet heavily.


I say each person has to do their own due diligence. I think pela is a good idea that is rare, and I do plan to bet some more, just not yet sure when. These events can come at any time out of the blue.

The best things longs can do is post anything, however remote that could impact ONCY. For example recently someone posted about Roche moving closer to PDAC. I found that interesting. Remember almost all PDAC patients were metatstatic.

Cheers
<< Previous
Bullboard Posts
Next >>